Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of Atrophic Vaginitis or Desquamative Inflammatory Vaginitis

NCT02313545 is registered in ClinicalTrials.gov with Izun Pharma Ltd as lead sponsor.

NCT NCT02313545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02313545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of Atrophic Vaginitis or Desquamative Inflammatory Vaginitis
Lead sponsor
Izun Pharma Ltd
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2014
Completion date
March 31, 2017
Enrollment
50 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic vaginitis